Health Care & Life Sciences » Pharmaceuticals » Pharmaceutical and medical device recalls | Pharmaceutical industry financial penalties in U.S. by violation type 1991-2015

Pharmaceutical industry financial penalties in the United States 1991-2015, by violation type

Pharmaceutical industry financial penalties in the U.S. from 1991 to 2015, by type of violation (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data describes the amount of money the pharmaceutical industry in the United States had to pay in financial penalties from 1991 to 2015, by the type of violation. Over this time the pharmaceutical industry paid some 1.7 billion USD in financial penalties due to poor manufacturing practices in which they sold drug products that failed to meet FDA standards or specifications.

Unlawful promotion 11090
Overcharging government health programs 5059
Financial violations 3562
Monopoly practices 2121
Poor manufacturing practices 1720
Kickbacks 743
Concealing data 267
Environmental violations 232
Illegal distribution 67
Multiple violations 10887